Compass Therapeutics Inc. (CMPX)
NASDAQ: CMPX
· Real-Time Price · USD
2.98
0.03 (1.02%)
At close: Aug 15, 2025, 3:59 PM
2.97
-0.34%
After-hours: Aug 15, 2025, 05:01 PM EDT
Compass Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 22.86M | 41.05M | 43.48M | 36.8M | 19.4M | 23.67M | 24.23M | 30.43M | 19.28M | 27.03M | 34.95M | 16.48M | 26.24M | 136.38M | 144.51M | 25.51M | 31.21M | 39.7M |
Short-Term Investments | 78.09M | 71.59M | 83.24M | 98.6M | 126.82M | 132.58M | 128.23M | 133.28M | 149.47M | 148.14M | 151.66M | 104.12M | 105.78M | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 568K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 210K | 210K | 151K |
Other Long-Term Assets | n/a | 568K | 568K | 568K | 320K | 320K | 320K | 320K | 320K | 320K | 320K | 320K | 320K | 320K | 320K | 320K | 320K | 320K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 5.25M | 11.51M | 6.03M | 5.74M | 7.32M | 2.36M | 1.42M | 2.88M | 6.52M | 8.43M | 8.18M | 1.95M | 2.53M | 3.9M | 2.59M | 3.06M | 3.33M | 1.95M |
Total Current Assets | 106.19M | 124.14M | 132.75M | 141.14M | 153.55M | 158.61M | 153.88M | 166.58M | 175.27M | 183.6M | 194.79M | 122.55M | 134.54M | 140.28M | 147.1M | 28.57M | 34.53M | 41.65M |
Property-Plant & Equipment | 9.94M | 6.74M | 7.08M | 7.44M | 1.75M | 2.21M | 2.67M | 3.13M | 3.59M | 4.05M | 4.53M | 4.96M | 5.39M | 5.96M | 6.33M | 5.8M | 5.81M | 6.08M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 10.5M | 7.31M | 7.65M | 8.01M | 2.06M | 2.53M | 2.99M | 3.45M | 3.91M | 4.37M | 4.85M | 5.28M | 5.71M | 6.28M | 6.65M | 6.33M | 6.34M | 6.55M |
Total Assets | 116.7M | 131.45M | 140.4M | 149.15M | 155.61M | 161.14M | 156.88M | 170.04M | 179.18M | 187.97M | 199.65M | 127.84M | 140.26M | 146.56M | 153.76M | 34.9M | 40.87M | 48.2M |
Account Payables | 2.6M | 1.58M | 2.25M | 960K | 1.19M | 854K | 4.09M | 2.31M | 724K | 1.13M | 3.38M | 2.76M | 6.53M | 257K | 867K | 868K | 559K | 1.06M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.74M | n/a | n/a |
Short-Term Debt | 271K | n/a | n/a | n/a | n/a | 1.22M | 1.2M | 1.17M | 1.15M | 1.12M | 1.1M | 1.07M | 1.05M | 1.03M | 989K | 4.82M | 6.66M | 8.5M |
Other Current Liabilities | 8.99M | 1.49M | 2.79M | n/a | n/a | 1.81M | 2.51M | 5.64M | 7.83M | 8.94M | 11.69M | 5.74M | 3.3M | 8.05M | 8.78M | 5.74M | 1.17M | 1.29M |
Total Current Liabilities | 13.86M | 14.9M | 8.87M | 4.43M | 9.51M | 3.89M | 7.8M | 9.12M | 9.7M | 11.19M | 16.17M | 9.58M | 10.88M | 9.33M | 10.63M | 7.68M | 8.39M | 10.85M |
Long-Term Debt | 9.63M | n/a | n/a | n/a | n/a | 189K | 536K | 869K | 1.2M | 1.52M | 1.84M | 2.14M | 2.44M | 2.74M | 3.05M | 3.33M | 3.6M | 3.88M |
Other Long-Term Liabilities | n/a | n/a | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 9.63M | 6.27M | 6.3M | 6.32M | n/a | 189K | 536K | 869K | 1.2M | 1.52M | 1.84M | 2.14M | 2.44M | 2.74M | 3.05M | 3.33M | 3.6M | 3.88M |
Total Liabilities | 23.49M | 21.17M | 15.17M | 10.75M | 9.51M | 4.08M | 8.34M | 9.99M | 10.89M | 12.71M | 18.01M | 11.72M | 13.33M | 12.07M | 13.68M | 11.01M | 12M | 14.73M |
Total Debt | 9.9M | 6.38M | 6.63M | 6.88M | 1.09M | 1.41M | 1.73M | 2.04M | 2.34M | 2.64M | 2.94M | 3.22M | 3.5M | 3.77M | 4.04M | 8.14M | 10.26M | 12.38M |
Common Stock | 14K | 14K | 13K | 14K | 14K | 14K | 13K | 13K | 13K | 13K | 13K | 10K | 10K | 10K | 10K | 6K | 6K | 5K |
Retained Earnings | -401.2M | -381.32M | -364.68M | -349.65M | -339.17M | -326.1M | -315.31M | -301.89M | -291.93M | -280.65M | -272.81M | -261.22M | -249.25M | -240.75M | -233.59M | -220.61M | -214.63M | -158.83M |
Comprehensive Income | 208K | 190K | 210K | 486K | -91K | -90K | 37K | -430K | -507K | -146K | -302K | -641K | -512K | 0.00 | 0.00 | n/a | n/a | -4.65M |
Shareholders Equity | 93.21M | 110.28M | 125.23M | 138.4M | 146.1M | 157.06M | 148.54M | 160.04M | 168.29M | 175.26M | 181.64M | 116.12M | 126.93M | 134.49M | 140.08M | 23.89M | 28.88M | 33.47M |
Total Investments | 78.66M | 71.59M | 83.24M | 98.6M | 126.82M | 132.58M | 128.23M | 133.28M | 149.47M | 148.14M | 151.66M | 104.12M | 105.78M | n/a | n/a | 210K | 210K | 151K |